Restatement of previously issued financial statements (Detail 3) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Jun. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Mar. 31, 2020	Mar. 31, 2019
Net Loss	$ (19,986,843)	$ (13,634,062)	$ (8,411,076)	$ (3,451,489)	$ (33,620,905)	$ (11,862,565)	$ 27,958,169	$ 42,036,100
Net Loss from Continuing Operations					33,620,905	12,624,333
Depreciation, Depletion, Amortization and Accretion	2,837		3,592		5,132	7,834
Share-Based Compensation					36,502	29,425
Loss from Equity Method Investment							957,169	0
Changes in Components of Working Capital and Other Assets:
Accounts Receivable					(55,060)	7,213
Accounts Payable and Accrued Expenses					(255,038)	(406,688)
Net Cash Used in Operating Activities					(1,343,650)	(2,837,903)
Net Cash Provided by (Used In) Investing Activities from Continuing Operations					(4,200,000)	(1,081,534)
Net Cash Used in Investing Activities from Discontinued Operations					0	(70,440)
Net Cash Used in Investing Activities					(4,200,000)	(1,151,974)
Net Cash Provided by (Used in) Financing Activities from Continuing Operations					6,000,000	(25,000)
Net Cash Provided by Financing Activities from Discontinued Operations					0	454,210
Increase (Decrease) in Cash					456,350	(3,560,667)
Adjustment [Member]
Net Loss	2,320,788		(5,366,234)		(4,017,646)	(5,366,234)
Net Loss from Continuing Operations					(4,017,646)	(5,366,234)
Depreciation, Depletion, Amortization and Accretion			0
Change in Fair Value of Derivative Liability					4,017,646	5,366,234
Restated [Member]
Net Loss	(19,986,843)		(8,411,076)		(33,620,905)	(11,862,565)
Net Income from Discontinued Operations					0	761,768
Net Loss from Continuing Operations					(33,620,905)	12,624,333
Depreciation, Depletion, Amortization and Accretion	2,837		3,592		5,132	7,834
Bad debt Expense					170,660	17,694
Share-Based Compensation					36,502	29,425
Loss from Equity Method Investment					2,140,121	0
Change in Fair Value of Derivative Liability					29,969,765	10,298,003
Changes in Components of Working Capital and Other Assets:
Accounts Receivable					55,060	(7,213)
Other Current Assets					155,053	23,414
Accounts Payable and Accrued Expenses					(255,038)	(409,688)
Net Cash Used in Operating Activities from Continuing Operations						(2,454,133)
Net Cash Used in Operating Activities from Discontinued Operations						(383,770)
Net Cash Used in Operating Activities					(1,343,650)	(2,837,903)
Cash Paid for Subsidiary						(1,050,000)
Cash Paid for Issuance of Notes Receivable					(4,200,000)	0
Cash Received for Deposits						(31,534)
Net Cash Provided by (Used In) Investing Activities from Continuing Operations						(1,081,534)
Net Cash Used in Investing Activities					(4,200,000)	(1,115,974)
Cash Paid for Settlement of Series B Preferred Stock Warrants						(25,000)
Proceeds from Issuance of Series C Preferred Stock					6,000,000	0
Net Cash Provided by (Used in) Financing Activities from Continuing Operations						(25,000)
Net Cash Provided by Financing Activities from Discontinued Operations						429,210
Increase (Decrease) in Cash					456,350	(3,560,667)
Cash at Beginning of the Period		656,615		7,778,723	656,615	7,778,723	7,778,723
Cash at End of the Period	1,112,965		4,218,056		1,112,965	4,218,056	656,615	7,778,723
Previously Restated [Member]
Net Loss					(29,603,259)	(6,496,331)
Net Income from Discontinued Operations					0	761,768
Net Loss from Continuing Operations					(29,603,259)	(7,258,099)
Depreciation, Depletion, Amortization and Accretion					5,132	7,834
Bad debt Expense					170,660	17,694
Share-Based Compensation					36,502	29,425
Loss from Equity Method Investment					2,140,121	0
Change in Fair Value of Derivative Liability					25,952,119	4,931,764
Changes in Components of Working Capital and Other Assets:
Accounts Receivable					55,060	(7,213)
Other Current Assets					155,038	234,145
Accounts Payable and Accrued Expenses					(255,038)	(409,683)
Net Cash Used in Operating Activities from Continuing Operations						(2,454,133)
Net Cash Used in Operating Activities from Discontinued Operations						(383,770)
Net Cash Used in Operating Activities					(1,343,650)	(2,837,903)
Cash Paid for Subsidiary						(1,050,000)
Cash Paid for Issuance of Notes Receivable					(4,200,000)	0
Cash Received for Deposits						(31,534)
Net Cash Provided by (Used In) Investing Activities from Continuing Operations						1,081,534
Net Cash Used in Investing Activities from Discontinued Operations						70,440
Net Cash Used in Investing Activities					(4,200,000)	1,151,974
Cash Paid for Settlement of Series B Preferred Stock Warrants						(25,000)
Proceeds from Issuance of Series C Preferred Stock					6,000,000	0
Net Cash Provided by (Used in) Financing Activities from Continuing Operations						25,000
Net Cash Provided by Financing Activities from Discontinued Operations						454,210
Increase (Decrease) in Cash					456,350	(3,560,667)
Cash at Beginning of the Period		$ 656,615		$ 7,778,723	656,615	7,778,723	7,778,723
Cash at End of the Period	$ 1,112,965		$ 4,218,056		$ 1,112,965	$ 4,218,056	$ 656,615	$ 7,778,723